Literature DB >> 9547122

The natural history of depression and the anxiety disorders in older people: the Islington community study.

G Livingston1, V Watkin, B Milne, M V Manela, C Katona.   

Abstract

BACKGROUND: This study reports the outcome of depression and anxiety disorders in older people.
METHODS: Follow-up of 165 subjects age 65 or over, initially identified in a community study in inner London as depressed or having an anxiety disorder.
RESULTS: 117 subjects still living in the area; 25 had died. Death was predicted only by activity limitation at first interview and not by other demographic or morbidity variables. Eighty-six subjects reinterviewed; 21 males, 65 females. Of the depressed, 34% had recovered, 39% were depressed and 27% were dead. Predictors from initial interview of continuing depression were female gender and more severe depression. Of those with phobic anxiety, 16% had recovered, 18% died and 66% were still phobic. Predictors of continuing phobic anxiety from initial interview were female gender and "stand-alone" phobic anxiety, i.e., not being depressed at initial interview. Sixty percent of those with early onset phobias had specific phobias; 82% of those with late-onset phobias had agoraphobia. Twenty-two subjects were prescribed psychotropics. The only significant predictor of psychotropic prescription was having sleep disturbance at initial interview. A low score on life satisfaction was significantly correlated with depression but not with phobic disorder. A high score was correlated with not having a current psychiatric disorder. LIMITATIONS: Some subjects were lost to follow-up. Those on psychotropics were particularly likely to refuse an interview. CONCLUSION AND CLINICAL RELEVANCE: In older people, neither depression nor the anxiety disorders generally remit spontaneously. Those with a particularly poor prognosis are women and those with a more severe depression. Agoraphobia may be precipitated in older people by stressful events and interferes with life satisfaction. There is potential for increased pharmacological treatment of older people with affective disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9547122     DOI: 10.1016/s0165-0327(97)00155-9

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Quality of life and psychological health indicators in the national social life, health, and aging project.

Authors:  Sharon Shiovitz-Ezra; Sara Leitsch; Jessica Graber; Amelia Karraker
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-02-09       Impact factor: 4.077

Review 2.  Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.

Authors:  Alastair J Flint
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

Review 4.  Diagnosis and management of panic disorder in older patients.

Authors:  Alastair J Flint; Nadine Gagnon
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 5.  Course and outcomes of depression in the elderly.

Authors:  Robert Kohn; Gary Epstein-Lubow
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

6.  Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons.

Authors:  Hsiao-Yun Lin; Wei-Lan Yeh; Bor-Ren Huang; Chingju Lin; Chih-Ho Lai; Ho Lin; Dah-Yuu Lu
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.